SEKISUI Diagnostic Debuts the Metrix® COVID/Flu Test
References: prnewswire
SEKISUI Diagnostics has introduced the Metrix® COVID/Flu Test, a molecular diagnostic tool designed to detect and differentiate SARS-CoV-2, Influenza A, and Influenza B from nasal swab samples. This test was developed in collaboration with Aptitude Medical Systems and builds on the two companies' previous partnership, which focused on distributing the Metrix® COVID-19 Test.
The Metrix® COVID/Flu Test offers results in just 20 minutes with minimal user involvement. This makes the molecular diagnostic tool suitable for point-of-care settings such as urgent care clinics, physician offices, and remote healthcare facilities, as well as for home use.
The Metrix® COVID/Flu Test's affordability, ease of use, and rapid turnaround time position it as a competitive option in the molecular diagnostics market. The emergency use authorization (EUA) from the FDA underscores the test’s reliability for detecting these specific viruses, though it is important to note that it has not received full FDA clearance.
Image Credit: SEKISUI Diagnostics
The Metrix® COVID/Flu Test offers results in just 20 minutes with minimal user involvement. This makes the molecular diagnostic tool suitable for point-of-care settings such as urgent care clinics, physician offices, and remote healthcare facilities, as well as for home use.
The Metrix® COVID/Flu Test's affordability, ease of use, and rapid turnaround time position it as a competitive option in the molecular diagnostics market. The emergency use authorization (EUA) from the FDA underscores the test’s reliability for detecting these specific viruses, though it is important to note that it has not received full FDA clearance.
Image Credit: SEKISUI Diagnostics
Trend Themes
-
Rapid-response Diagnostic Tools — The demand for quick-result diagnostic tools is rising, offering possibilities for innovative applications in point-of-care diagnostics.
-
Multi-virus Detection Solutions — With the ability to simultaneously detect multiple viruses, diagnostic tests are expanding their role in comprehensive infectious disease management.
-
At-home Testing Evolves — The growth of user-friendly at-home testing kits creates new opportunities for consumer-centric healthcare solutions.
Industry Implications
-
Healthcare Diagnostics — Advancements in diagnostics are transforming healthcare delivery by enhancing capabilities for rapid and accurate disease detection.
-
Telehealth Services — As diagnostics become increasingly accessible at home, telehealth services can further integrate and utilize these tools for remote patient management.
-
Medical Device Manufacturing — The innovation in diagnostic tools spurs opportunity for manufacturers to develop versatile and efficient testing solutions that meet evolving healthcare needs.
3.1
Score
Popularity
Activity
Freshness
